Emma’s adverse reaction to Tegretol

Emma’s adverse reaction to Tegretol is a suspected medication-related episode during her PAAZ admission, in which abdominal pain, severe breathlessness, weakness, and elevated vital signs turn a treatment change into an urgent medical concern. Its significance extends beyond the physical symptoms: it renews the possibility of a serious reaction to psychiatric medication, delays Emma’s return to ordinary life, and sharpens her dread of being a patient again.

The physical episode and its assessment

Emma’s symptoms become difficult to manage after she returns from the chapel. She is found on the floor, wedged between her bed and wardrobe, and struggles to formulate a coherent explanation. She recalls intense abdominal pain and frightening breathlessness on the way back. Standing is so difficult that she may fall; the rigid, enclosed space between the furniture offers a brief, impersonal kind of order while her body and thoughts feel unmanageable.

Bas arrives to measure her blood pressure and is alarmed by her condition. Her blood pressure and heart rate are again too high, so he considers calling the psychiatrist. Emma manages, slowly and in stages, to get upright, but ends bent over the bed, gasping. Her joke that she is not disabled and her weary attempt to make light of the effort do not reassure Bas. He calls the doctor and asks whether the abdominal pain is continuing.

Rajid is concerned partly because Emma had a severe reaction to new medication during her previous admission. After consulting Dokter Valk, he raises the concern that her symptoms are developing in a troubling way. By the time the physical examination is over, Emma is exhausted and leans against the door to the locked ward, too depleted even to press the call bell. Iefke and Linda, who saw her with the doctor in the garden, find her there and ask what has happened. Emma identifies the problem as side effects and says she needs to go to hospital for a check-up.

Medication and the limits of certainty

At Spoedeisende Hulp, Emma lists lithium and temazepam alongside Tegretol, which she had started only a few days before the symptoms began. She understands Tegretol as a medication that can stabilize mood, though it is also used for epilepsy. The timing leads her to suspect that the new medication is responsible. The examining doctor sees no reason to keep her there and, after hearing that the symptoms began when she started the pills, recommends stopping them.

The conclusion is based on the sequence Emma reports, not on a detailed explanation of the mechanism or a confirmed diagnosis in the available account. The episode is therefore presented as a suspected adverse reaction rather than a medically established cause. For Emma, that distinction does little to lessen the immediate strain: she feels almost like the healthiest person in the emergency department, yet she is unwell enough to need an examination and to be sent back into the hospital’s care system.

Stopping the medication does not feel like a simple resolution. Emma understands that discontinuing these pills means beginning another treatment, and she expects the next change the following week. That is also the week she had expected to return to work. Instead, she remains at the PAAZ over the weekend rather than spending it with Sergei. His reassurance that another weekend will come sounds to her less like comfort than a reminder of how uncertain her recovery feels; she desperately hopes there will not be another weekend as a psychiatric patient.

Symptoms amid psychiatric uncertainty

The medication episode unfolds alongside conversations about experiences that are not reducible to physical side effects. Rajid explains the distinction between hallucinations, in which perception is altered, and delusions, in which a person draws false conclusions from an otherwise accurate perception. He suggests that Emma has regularly experienced hallucinations. The conversation makes room for the fact that psychiatric symptoms can feel real and consequential without being the same kind of experience as abdominal pain, breathlessness, or a change in vital signs.

Emma describes a period when emotional numbness and a fixed belief that she had to die displaced ordinary concerns. After months of depression, the thought arrived with an overwhelming sense of clarity and certainty; she understood it not as a suicide plan in the usual sense but as something that simply had to happen. She recalls feeling no emotion when told that Dokter Visser’s husband had died, and says that the idea of her own death seemed to absorb everything else. Her account shows why outward calm or a claim of clarity cannot, by itself, be taken as evidence that she is safe or well.

She also explains that believing something is different from merely thinking it. During a manic delusion, she believed she could fly: the conviction felt not strange but normal, as though the world had finally become what it was supposed to be. These accounts place the Tegretol episode within a broader treatment context, but the narrative does not establish that the medication caused Emma’s hallucinations, suicidal beliefs, or flight delusion. Keeping those experiences distinct matters: the physical episode raises one kind of concern, while her altered perceptions and certainty raise others.

Care, dependence, and the fear of recurrence

Emma’s experience of care is shaped by the fact that she is an inpatient. A person receiving outpatient treatment can call a doctor’s secretary directly for an appointment; a patient on the ward must pass a request to nursing staff, wait for it to be raised at the next morning meeting, and depend on the psychiatrist and secretary to arrange and relay a time. Emma contrasts a process that may take five minutes outside the hospital with one that can take much longer inside it. In the evening, she is told, nothing further can happen. The procedural delay contributes to her anger and to the sense that, as a patient, she has little control over when she can obtain help.

The fear that treatment may require another medication change is also bound up with relationships. Emma later tells another patient that Sergei took more than three weeks and two conversations with her psychiatrist before he removed her stockpiled medication, and that he did so reluctantly. She worries that his resistance means he does not take her suffering seriously. The other patient offers a different interpretation: Sergei may be trying to protect himself from the implication that Emma’s danger was truly life-threatening. This does not settle their disagreement, but it shows how the practical management of medication can become a test of whether the people close to Emma recognize the seriousness of her illness.

A conversation with Beatrice supplies a distinct, not equivalent, account of medication and distress. Beatrice says that after beginning pills during an earlier stay, she stopped feeling God’s presence and went home hoping it would return if she stopped taking them. It did not, and she later returned to the PAAZ. Emma cannot claim to share that experience, but she responds that depression might suppress the energy needed to believe, just as it can suppress the energy to laugh or love. The exchange underscores that medication and illness acquire different meanings for different patients; Beatrice’s account is not evidence that Emma’s Tegretol reaction had the same spiritual or emotional effects.

Recurrence rather than a clean recovery

The episode is framed against Emma’s wish to separate an earlier depression from the present. She imagines recovery as a change in what can be seen: when the fog lifts, the world appears newly clear and its hidden scale and order seem suddenly visible. Yet that clarity is not necessarily a sign of safety. In the account of her suicidal conviction, the feeling of understanding everything is part of what makes the belief compelling; in the account of flying, delusion presents itself as an arrival at normality. The contrast unsettles any simple division between feeling clear and being well.

Depression, by contrast, is described through the collapse of time and self. Emma recalls the fear that follows when she can no longer keep a lifelong memory at bay: the self seems reduced to fragments struggling to hold on to life. Elsewhere, she contrasts mania’s consuming present with depression’s engulfment of the future by the past. These passages do not identify the cause of the Tegretol symptoms, but they explain why a physical setback can carry such emotional weight within an already recurring illness.

The medication reaction therefore does not end in a straightforward cure or a settled explanation. Emma faces the prospect of stopping Tegretol, trying another treatment, remaining hospitalized, and postponing her return to work. Later, in a conversation with Lars, she asks to be let go while acknowledging that things may become worse again. That admission does not erase the need for care; it expresses the difficult recognition that improvement may not mean permanent freedom from recurrence. The episode belongs to a larger movement away from the hope that one successful treatment will close the story and toward the harder task of living with an illness whose symptoms, treatments, and risks can change.